NSE · NEPHROPLUS
Nephrocare Health Services Limited (NEPHROPLUS) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#740
of 5,047 stocks
▲ 151W▲ 191M
Peak #685 · 21 Sep 2026
Nephrocare Health Services Limited is a midcap company in the Healthcare space and carries a steep earnings multiple that prices in strong future growth, is growing revenue rapidly, and remains firmly promoter-controlled, with promoters holding 64%.
Market Cap
6,455.95 Cr
P/E Ratio
75.71
P/B Ratio
5.77
ROE
6.88%
ROCE
13.73%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 303.40 Cr | 281.75 Cr | 265.62 Cr | 259.73 Cr |
| Net Profit | 33.53 Cr | 31.97 Cr | 30.37 Cr | 32.24 Cr |
| EPS | 3.34 | 3.19 | 3.03 | 3.35 |
| Operating Profit | 47.43 Cr | 46.80 Cr | 39.49 Cr | 42.32 Cr |
Shareholding pattern
Promoter
63.85%
Public
36.15%
PUBLIC BREAKDOWN
FII
8.78%
DII
9.05%
MF (within DII)
3.20%
Individuals
6.10%
Mutual fund holdings
₹275.36
Cr total
24
Schemes
12
Fund Houses
₹275.36 Cr
Total Exposure
SBI Mutual Fund₹65.66 Cr (23.8%)
LIC Mutual Fund₹60.92 Cr (22.1%)
Bandhan Mutual Fund₹60.70 Cr (22.0%)
DSP Mutual Fund₹39.02 Cr (14.2%)
Helios Mutual Fund₹23.43 Cr (8.5%)
Others₹25.63 Cr (9.3%)
| Scheme | Fund House | Value (Cr) | % |
|---|
Recent corporate actions
No corporate actions on record for this stock.
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.